Halimodendron halodendron
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Halimodendron halodendron |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Halimodendron Halodendron |
| Ipni Id | 497237-1 |
| Plant Name | Halimodendron Halodendron |
| Genus Tax Id | 47656 |
| Disease Name | Atopic eczema, Crohn disease, Choreiform disorder, Acute myeloid leukaemia, Tonus and reflex abnormality, Reactive arthropathy, Inherited coagulation factor deficiency, Indeterminate colitis, Solid tumour/cancer, Genetic prion disease, Skin and skin-structure infection, Spinal pain, Alzheimer disease, Joint pain, Pain, unspecified, Mood disorder, Cerebral ischaemia, Systemic sclerosis, Nutritional deficiency, Inflammatory spondyloarthritis, Osteoarthritis, Cardiovascular disease, Migraine, Parkinsonism, Postoperative inflammation, Ulcerative colitis, Rheumatoid arthritis, Ataxic disorder, Diabetes mellitus, type unspecified, Muscular dystrophy, Parasitic infection, Fungal infection, Chronic obstructive pulmonary disease, Endometriosis, Acute/subacute hepatic failure, Myocardial infarction, Eye anterior segment structural developmental anomaly, Otitis media, Hyper-lipoproteinaemia, HIV-infected patients with tuberculosis, Neuropathy, Multiple sclerosis, Colorectal cancer, Colon cancer, Type 2 diabetes mellitus, Mild neurocognitive disorder, Psoriasis, Autonomic nervous system disorder, Asthma, Vasculitis, Urinary system disease, Irritable bowel syndrome, Lupus erythematosus, Female pelvic pain, Seborrhoeic dermatitis, Intermediate hyperglycaemia, unspecified, Schizophrenia, Obstructive sleep apnoea, Huntington disease, Polycystic ovary syndrome, Non-small cell lung cancer, Diabetes mellitus arising in pregnancy, Breast cancer, Periodontal disease, Neurobehavioral disorder, Prostate cancer, Head and neck cancer, Endometrial cancer, Fragile X chromosome, Coronary atherosclerosis, Adenocarcinoma, Diffuse large B-cell lymphoma, Secondary progressive multiple sclerosis, Endometrial glandular hyperplasia, Inborn lipid metabolism error, Malignant neoplasm of pancreas, unspecified, Squamous cell carcinoma of oropharynx, Melanoma, Obesity, Metabolic disorder, Symptoms and signs involving cognition, unspecified, Autosomal dominant polycystic kidney disease, Sex development malformative disorder, Glioblastoma, primary, NOS, Pulmonary hypertension, Chronic arterial occlusive disease, unspecified, Rectum cancer, Squamous cell carcinoma, Chronic kidney disease, Ageing associated decline in intrinsic capacity, Pregnancy/childbirth/puerperium maternal infection, Neoplasms, Primary progressive multiple sclerosis, Blindness, Other specified malignant neoplasms of colon, Becker muscular dystrophy, Urogenital cancer, Multiple myeloma, Neuroendocrine carcinoma, Follicular lymphoma, Non-alcoholic fatty liver disease, Type1diabetesmellitus, Large cell carcinoma of bronchus or lung, Primary neoplasms of brain, Acute viral hepatitis, Neuropathic pain, Male infertility, Hypopituitarism, Central diabetes insipidus, Cervical cancer, Malignant neoplasm metastasis in male genital organs, Adenocarcinoma of prostate, Small cell carcinoma of bronchus or lung, Ovarian cancer, Breast in situ carcinoma, Thyroid cancer, Spastic cerebral palsy, Impaired glucose tolerance, Lung cancer, Schizoaffective disorder, Retinopathy, Lipoatrophy/lipodystrophy, Acute ischaemic heart disease, unspecified, Duchenne muscular dystrophy, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Hidradenitis suppurativa, Malignant neoplasms of bladder, unspecified, Columnar metaplastic epithelium of the oesophagus, unspecified, Hypercholesterolaemia, Heart failure, Diabetic foot ulcer, Insulin-resistance syndromes, Severe acute respiratory syndrome, Migraine disorder(TM1), Angiosarcoma, COVID-19, Disorders of intellectual development, unspecified, Chronic lymphocytic leukaemia or small lymphocytic lymphoma, Leprosy, Malignant neoplasms of prostate, unspecified, Malignant neoplasms of ill-defined sites, Generalised anxiety disorder, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Adenocarcinoma, endocervical type, Burn and burn infection, Malignant neoplasms of colon, Aneurysm/dissection, Unspecified malignant neoplasms of unspecified sites, Schizophrenia or other primary psychotic disorders, unspecified, coronary artery disease, Carcinomas of ovary, Polyneuropathy, unspecified, Other specified non-alcoholic fatty liver disease, Sickle-cell disorder, Osteosarcoma of bone and articular cartilage of other specified sites, Glaucoma, Malignant neoplasm metastasis, unspecified, Hepatocellular carcinoma, NOS, Precursor cell lymphoblastic leukaemia, NOS, Atrial fibrillation, Bipolar disorder, Macular degeneration, Malaria, Liver cancer, Single episode depressive disorder, severe, without psychotic symptoms, Low back pain, Dementia, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Inflammatory bowel diseases, unspecified, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Hepatocellular carcinoma of liver, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Cytomegaloviral disease, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Malignant neoplasms of thymus, Glioblastoma of brain, Germ cell tumour of testis, Carpal tunnel syndrome, Malignant neoplasms of adrenal gland, Gliomas of brain |
| Species Name | Halimodendron halodendron |
| Genus Name | Halimodendron |
| Species Tax Id | 47657 |
| Disease Id | EA80, DD70, 8A01, 2A60, MB47, FA11, 3B14, DD72, 2A00-2F9Z, 8.00E+02, 1F28-1G0Z, ME84, 8A20, ME82, MG3Z, 6A60-6E23, 8B1Z, 4A42, 5B50-5B71, FA92, FA00-FA05, BA00-BE2Z, 8A80, 8A00, 1A00-CA43, DD71, FA20, 8A03, 5A14, 8C70, 1D0Y-1G2Z, 1F29-1F2F, CA22, GA10, DB91, BA41-BA43, LA11, AA80-AB0Z, 5C80, 1B10-1B14, 8C0Z, 8A40, 2B91, 2B90, 5A11, 6D71, EA90, 8D87, CA23, 4A44, GC2Z, DD91, 4A40, GA34, EA81, 5A40.Z, 6A20, 7A41, 8A01.10, 5A80.1, 2C25, JA63.2, 2C60-2C6Y, DA0C, 8A00-8A0Z, 2C82, 2D42, 2C76, LD55, BA80, 2D40, 2A81, 8A40.2, GA16.0, 5C52, 2C10.Z, 2B6A.0, 2C30, 5B80-5B81, 5C50-5D2Z, MB21.Z, GB81, LD2A, XH0MB1, BB01, BD4Z, 2B92, 2B60-2D01, GB61, MG2A, JB63, 2, 8A40.1, 9D90.6, 2B90.Y, 8C70.0, 2C95-2C9Z, 2A83, 2C34, 2A80, DB92, 5A10, 2C25.3, 2A00, 8E43.0, GB04, 5A61.0, 5A61.5, 2C77, 2.00E+06, 2C82.0, 2C25.1, 2C73, 2.00E+65, 2D10, 8D20, 5A40.1, 6A21, 9B71, EF01, BA4Z, 8C70.1, 2D60.0, ED92, 2C94.Z, DA23.Z, 5C80.0, BD10-BD1Z, BD54, 5A44, 1D65, SD10, 2B56, 1D6Y, 6A00.Z, 2A82.0, 1B20, 2C82.Z, 6B00, 1C62.Z, XH0GS9, ND90-NE2Z, BD50, 2D4Z, 6A2Z, BA8Y-BA8Z, 2C73.0, DB92.Y, 3A51, 2B51.Y, 9C61, 2E2Z, XH4W48, XH5J37, BC81.3, 6A60, 9B75, 1F40-1F45, 2C12, 6A70.3, ME84.2, 6D80-6D8Z, 2C76.43, 2C73.4, XH3854, DD7Z, FA0Z, 2C15, 2C12.01, 1F54, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2C12.02, GA10.B4, 2B70, 1D82, 2D10.Z, 2C76.Z, 1D40, 2C27, 2A00.00, 2C80.2, 8C10.0, 2D11, 2A00.0 |
| Family Name | Fabaceae |
| Family Tax Id | 3803 |
- 1. (1r,2r)-1,8,10-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-9-(3-Methylbut-2-Enyl)-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 163186423)
- 2. (2r)-2,6,11-Trihydroxy-3,3,9-Trimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163069831)
- 3. (2r)-4-Hydroxy-2-(2-Hydroxypropan-2-Yl)-7,8-Dimethoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163048406)
- 4. (2r,3s)-2-(3,5-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 6325418)
- 5. (2s)-2,6,9,11-Tetrahydroxy-3,3-Dimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163048792)
- 6. (2s)-4,7-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-11-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163007755)
- 7. (2s)-4,7-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 154496056)
- 8. (2s)-4,8,10-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-9-(3-Methylbut-2-Enyl)-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 162980002)
- 9. (2s)-4,8,10-Trihydroxy-9-(3-Methylbut-2-Enyl)-2-Prop-1-En-2-Yl-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 163031668)
- 10. (2s)-4,8-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-7-Methoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 162957066)
- 11. (2s)-4,8-Dihydroxy-7-Methoxy-6-(3-Methylbut-2-Enyl)-2-Prop-1-En-2-Yl-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163087336)
- 12. (2s)-4,9-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-11-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 162987335)
- 13. (2s,3r)-3,4,8-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-7-Methoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 11546716)
- 14. (2s,3s)-2,3,8-Trihydroxy-6-Methoxy-7-(3-Methylbut-2-Enyl)-1,2,3,4-Tetrahydroxanthen-9-One (PubChem CID: 163065723)
- 15. (3beta,23e)-3-Hydroxy-9,19-Cyclo-27-Norlanost-23-En-25-One (PubChem CID: 21626061)
- 16. (3r)-3,9-Dihydroxy-5,10-Dimethoxy-2,2-Dimethyl-11-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[2,3-A]xanthen-12-One (PubChem CID: 163082788)
- 17. (3r)-5,8-Dihydroxy-3-Methyl-3,4-Dihydroisochromen-1-One (PubChem CID: 10442609)
- 18. (3r)-8-Hydroxy-3-Methyl-3,4-Dihydro-1h-2-Benzopyran-1-One (PubChem CID: 114679)
- 19. (3s)-3,5,9-Trihydroxy-10-Methoxy-2,2-Dimethyl-11-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[2,3-A]xanthen-12-One (PubChem CID: 162842817)
- 20. (3s)-3,5,9-Trihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[3,2-B]xanthen-6-One (PubChem CID: 92448128)
- 21. (3s,4s)-4-Acetyl-3-Methyloxolan-2-One (PubChem CID: 118708002)
- 22. (4s,8r)-8,14-Dihydroxy-16-Methoxy-4-Methyl-3-Oxabicyclo[10.4.0]hexadeca-1(12),13,15-Trien-2-One (PubChem CID: 134142479)
- 23. (5r) 5-Hydroxylasiodiplodin (PubChem CID: 10638525)
- 24. (5s) 5-Hydroxylasiodiplodin (PubChem CID: 10733600)
- 25. (6r)-15-Hydroxy-9-Methoxy-19,19-Dimethyl-6-Propan-2-Yl-7,12,20-Trioxapentacyclo[11.8.0.03,11.04,8.016,21]henicosa-1(13),3,8,10,14,16(21)-Hexaen-2-One (PubChem CID: 162875726)
- 26. (E,6s)-6-[(1s,3r,7s,8r,11s,12s,15r,16r)-7-Hydroxy-7,12,16-Trimethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-3-En-2-One (PubChem CID: 162908349)
- 27. 1,3,6,7-Tetrahydroxy-8-Prenylxanthone (PubChem CID: 15307924)
- 28. 1,3,6-Trihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-7-Methoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 156908054)
- 29. 1,3,7-Trihydroxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methylbutyl)-Xanthone (PubChem CID: 102234393)
- 30. 1,3,7-Trihydroxy-2-Methoxyxanthone (PubChem CID: 12133315)
- 31. 1,3,7-Trihydroxy-2-Prenylxanthone (PubChem CID: 5495920)
- 32. 1,3,7-Trihydroxy-6-Methyl-2,8-Bis(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163003410)
- 33. 1,3-Dihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-6,7-Dimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162924938)
- 34. 1,4,5,6-Tetrahydroxy-2-(2-Methylbut-3-En-2-Yl)xanthen-9-One (PubChem CID: 10426622)
- 35. 1,5,8-Trihydroxy-3-Methyl-2,4-Bis(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162980068)
- 36. 1,5-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 10449043)
- 37. 1,6,7-Trihydroxy-8-(3-Hydroxy-3-Methylbutyl)-3-Methyl-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162851978)
- 38. 1,6-Dihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,7-Dimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162962935)
- 39. 1,6-Dihydroxy-3,7-Dimethoxy-2-(3-Methyl-2-Butenyl)-8-(2-Oxo-3-Methyl-3-Butenyl)-Xanthone (PubChem CID: 129847853)
- 40. 1,6-Dihydroxy-3,7-Dimethoxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methyl-1e-Butenyl)-Xanthone (PubChem CID: 5319262)
- 41. 1,6-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 14162675)
- 42. 1,6-Dihydroxy-8-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,7-Dimethoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162871148)
- 43. 1,7-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 509269)
- 44. 1,8-Dihydroxy-3-Methoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162890971)
- 45. 1-(3,3-Dimethylbutyl)-3,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 89172625)
- 46. 1-[(2s)-2,3-Dihydroxy-3-Methylbutyl]-3,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163010748)
- 47. 1-Hydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,6,7-Trimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162956670)
- 48. 1-Hydroxy-3,6,7-Trimethoxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methyl-1e-Butenyl)-Xanthone (PubChem CID: 5319715)
- 49. 1-Hydroxy-8-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,6,7-Trimethoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163021718)
- 50. 1-Isomangostin (PubChem CID: 5281641)
- 51. 10,22-Dihydroxy-7,7,18,18-Tetramethyl-8,13,17-Trioxapentacyclo[12.8.0.03,12.04,9.016,21]docosa-1(22),3(12),4(9),10,14,16(21),19-Heptaen-2-One (PubChem CID: 56840488)
- 52. 11alpha-Mangostanin (PubChem CID: 46880204)
- 53. 2,4,6,3',5'-Pentahydroxybenzophenone (PubChem CID: 19910294)
- 54. 2-(1,1-Dimethyl-2-Propenyl)-1,4,5-Trihydroxy-9h-Xanthen-9-One (PubChem CID: 364825)
- 55. 2-(3,7-Dimethylocta-2,6-Dienyl)-1,3,5,8-Tetrahydroxyxanthen-9-One (PubChem CID: 72988981)
- 56. 2-(3,7-Dimethylocta-2,6-Dienyl)-1,3,5-Trihydroxyxanthen-9-One (PubChem CID: 5495932)
- 57. 2-[(2r)-2,3-Dimethylbut-3-Enyl]-1,3,6-Trihydroxy-7-Methoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162852100)
- 58. 2-[4,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)-9-Oxoxanthen-1-Yl]acetaldehyde (PubChem CID: 163088729)
- 59. 3',6-Dihydroxy-2,4,4'-Trimethoxybenzophenone (PubChem CID: 101763992)
- 60. 3,4,5,3'-Tetrahydroxybenzophenone (PubChem CID: 52948815)
- 61. 3,5,9-Trihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-2-Enyl)pyrano[3,2-B]xanthen-6-One (PubChem CID: 68229267)
- 62. 3,6-Dimethylmangostin (PubChem CID: 231412)
- 63. 3-Ethyl-4-Methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]pyrrole-2,5-Dione (PubChem CID: 100933901)
- 64. 3-Isomangostin (PubChem CID: 13873655)
- 65. 4,8-Dihydroxy-7-Methoxy-6-(3-Methylbut-2-Enyl)furo[3,2-B]xanthen-5-One (PubChem CID: 162846027)
- 66. 4-Hydroxy-7,8-Dimethoxy-6-(3-Methylbut-2-Enyl)furo[3,2-B]xanthen-5-One (PubChem CID: 101193830)
- 67. 5,8,9-Trihydroxy-2,2-Dimethyl-10-(3-Methylbut-2-Enyl)pyrano[3,2-B]xanthen-6-One (PubChem CID: 10046140)
- 68. 5,9,11-Trihydroxy-3,3-Dimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 11696901)
- 69. 5,9,11-Trihydroxy-3,3-Dimethyl-6,10-Bis(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163091100)
- 70. 5,9-Dihydroxy-2,2,11,11-Tetramethyl-8-(3-Methyl-2-Butenyl)-2h-Dipyrano[2,3-A:2',3'-J]xanthen-14(11h)-One (PubChem CID: 71437595)
- 71. 5,9-Dihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-3-Enyl)-3,4-Dihydropyrano[3,2-B]xanthen-6-One (PubChem CID: 163013585)
- 72. 5-Hydroxy-8-[5-Hydroxy-7-Methoxy-2-(4-Methoxyphenyl)-4-Oxochromen-8-Yl]-7-Methoxy-2-(4-Methoxyphenyl)chromen-4-One (PubChem CID: 11103936)
- 73. 6-Deoxy-Gamma-Mangostin (PubChem CID: 13873657)
- 74. 6-Methylsalicylic Acid (PubChem CID: 11279)
- 75. 7-Methoxy-2-(3-Methyl-2-Butenyl)-8-(3-Methyl-2-Oxo-3-Butenyl)-1,3,6-Trihydroxyxanthone (PubChem CID: 69074110)
- 76. 8-Deoxygartanin (PubChem CID: 392450)
- 77. 8-Hydroxycudraxanthone G (PubChem CID: 11711264)
- 78. 9-Hydroxycalabaxanthone (PubChem CID: 5495929)
- 79. 9-Hydroxycalabaxanthone Hydrate (PubChem CID: 56840489)
- 80. [2,4-Dihydroxy-6-[(2s,3s,4s,5s,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyphenyl]-Phenylmethanone (PubChem CID: 162864269)
- 81. Astilbin (PubChem CID: 119258)
- 82. Beta-Mangostin (PubChem CID: 5495925)
- 83. Botryosphaeridione (PubChem CID: 44605081)
- 84. Botryosphaerihydrofuran (PubChem CID: 44605288)
- 85. Botryosphaerilactone A (PubChem CID: 102161309)
- 86. Botryosphaerilactone B (PubChem CID: 44605080)
- 87. Botryosphaerilactone C (PubChem CID: 102161308)
- 88. Botryosphaerinone (PubChem CID: 102161310)
- 89. Br-Xanthone A (PubChem CID: 13964005)
- 90. Br-Xanthone B (PubChem CID: 14034125)
- 91. Brasilixanthone B (PubChem CID: 5324261)
- 92. Cianidanol (PubChem CID: 9064)
- 93. Cis-4-Hydroxymellein (PubChem CID: 10420140)
- 94. Cowagarcinone B (PubChem CID: 5316764)
- 95. Cratoxyxanthone (PubChem CID: 46879489)
- 96. Cudraxanthone G (PubChem CID: 42645953)
- 97. Demethylcalabaxanthone (PubChem CID: 509270)
- 98. Dihydro-4-(Hydroxymethyl)-3,5-Dimethyl-2 (PubChem CID: 102125217)
- 99. Dulxanthone D (PubChem CID: 10405091)
- 100. Egonol (PubChem CID: 485186)
- 101. Epicatechin (PubChem CID: 72276)
- 102. Euxanthone (PubChem CID: 5281631)
- 103. Gamma-Mangostin (PubChem CID: 5464078)
- 104. Garcimangosone A (PubChem CID: 10874207)
- 105. Garcimangosone B (PubChem CID: 11143989)
- 106. Garcimangosone D (PubChem CID: 11003703)
- 107. Garcinone A (PubChem CID: 70689919)
- 108. Garcinone B (PubChem CID: 5495928)
- 109. Garcinone C (PubChem CID: 44159808)
- 110. Garcinone D (PubChem CID: 5495926)
- 111. Garcinone E (PubChem CID: 10298511)
- 112. Gartanin (PubChem CID: 5281633)
- 113. Gentisein (PubChem CID: 5281635)
- 114. Lasiodiplodin (PubChem CID: 14562696)
- 115. Lasiolactone (PubChem CID: 89352705)
- 116. Macluraxanthone (PubChem CID: 5281646)
- 117. Maclurin (PubChem CID: 68213)
- 118. Mangostenone A (PubChem CID: 509267)
- 119. Mangostenone B (PubChem CID: 21672078)
- 120. Mangostin (PubChem CID: 5281650)
- 121. Mangostinone (PubChem CID: 6478778)
- 122. Metformin (PubChem CID: 4091)
- 123. Norathyriol (PubChem CID: 5281656)
- 124. O-Demethylforbexanthone (PubChem CID: 45269778)
- 125. Proanthocyanidin A1 (PubChem CID: 9872976)
- 126. Procyanidin A2 (PubChem CID: 124025)
- 127. Procyanidin B2, (+)- (PubChem CID: 122738)
- 128. Procyanidin B5 (PubChem CID: 124017)
- 129. Rubraxanthone (PubChem CID: 9953366)
- 130. Smeathxanthone A (PubChem CID: 11509473)
- 131. Tetrahydro-4-Hydroxy-6-Propylpyran-2-One (PubChem CID: 130907047)
- 132. Thwaitesixanthone (PubChem CID: 392169)
- 133. Tovophyllin A (PubChem CID: 42645954)
- 134. Tovophyllin B (PubChem CID: 509268)
- 135. Trans-4-Hydroxymellein (PubChem CID: 10262028)
- 136. Trapezifolixanthone (PubChem CID: 188341)
- 1. Adenocarcinoma
- 2. Alzheimer's Disease 1
- 3. Arthritis, Rheumatoid
- 4. Asthma
- 5. Cardiovascular Diseases
- 6. Cholera
- 7. Coronary Artery Disease
- 8. Crohn Disease
- 9. Dementia
- 10. Diabetes Insipidus
- 11. Diabetes Mellitus
- 12. Diabetes Mellitus, Type 1
- 13. Glaucoma
- 14. Infertility, Male
- 15. Inflammatory Bowel Diseases
- 16. Leprosy
- 17. Liver Neoplasms
- 18. Muscular Dystrophies
- 19. Myocardial Infarction
- 20. Neoplasms
- 21. Obesity
- 22. Osteoarthritis
- 23. Psoriasis
- 24. Scleroderma, Systemic
- 25. Spondylitis
- 26. Urinary Bladder Neoplasms
- 27. Urinary System Disease
Not listed in any formulations.